202 related articles for article (PubMed ID: 18789992)
1. Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2.
Moreira LO; Smith AM; DeFreitas AA; Qualls JE; El Kasmi KC; Murray PJ
Vaccine; 2008 Oct; 26(46):5808-13. PubMed ID: 18789992
[TBL] [Abstract][Full Text] [Related]
2. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
Leclerc C; Audibert F; Chedid L
Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
[TBL] [Abstract][Full Text] [Related]
3. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
[TBL] [Abstract][Full Text] [Related]
4. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
[TBL] [Abstract][Full Text] [Related]
5. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction.
Yang Z; Fuss IJ; Watanabe T; Asano N; Davey MP; Rosenbaum JT; Strober W; Kitani A
Gastroenterology; 2007 Nov; 133(5):1510-21. PubMed ID: 17915219
[TBL] [Abstract][Full Text] [Related]
6. Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88.
Seubert A; Calabro S; Santini L; Galli B; Genovese A; Valentini S; Aprea S; Colaprico A; D'Oro U; Giuliani MM; Pallaoro M; Pizza M; O'Hagan DT; Wack A; Rappuoli R; De Gregorio E
Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11169-74. PubMed ID: 21690334
[TBL] [Abstract][Full Text] [Related]
7. Freund's adjuvant, NOD2 and mycobacteria.
Behr MA; Divangahi M
Curr Opin Microbiol; 2015 Feb; 23():126-32. PubMed ID: 25483349
[TBL] [Abstract][Full Text] [Related]
8. Surface calreticulin mediates muramyl dipeptide-induced apoptosis in RK13 cells.
Chen D; Texada DE; Duggan C; Liang C; Reden TB; Kooragayala LM; Langford MP
J Biol Chem; 2005 Jun; 280(23):22425-36. PubMed ID: 15817475
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties.
Gobec M; Tomašič T; Štimac A; Frkanec R; Trontelj J; Anderluh M; Mlinarič-Raščan I; Jakopin Ž
J Med Chem; 2018 Apr; 61(7):2707-2724. PubMed ID: 29543461
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of NOD1 or NOD2 and TLR4 activation on mouse sickness behavior in relation to immune and brain activity markers.
Farzi A; Reichmann F; Meinitzer A; Mayerhofer R; Jain P; Hassan AM; Fröhlich EE; Wagner K; Painsipp E; Rinner B; Holzer P
Brain Behav Immun; 2015 Feb; 44():106-20. PubMed ID: 25218901
[TBL] [Abstract][Full Text] [Related]
11. Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant.
Dubé JY; McIntosh F; Zarruk JG; David S; Nigou J; Behr MA
Sci Rep; 2020 Apr; 10(1):5874. PubMed ID: 32246076
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of structurally related peptidoglycan monomer and muramyl dipeptide on humoral IgG immune response to ovalbumin in mouse.
Habjanec L; Halassy B; Tomasić J
Int Immunopharmacol; 2010 Jul; 10(7):751-9. PubMed ID: 20403461
[TBL] [Abstract][Full Text] [Related]
13. Nod2-dependent Th2 polarization of antigen-specific immunity.
Magalhaes JG; Fritz JH; Le Bourhis L; Sellge G; Travassos LH; Selvanantham T; Girardin SE; Gommerman JL; Philpott DJ
J Immunol; 2008 Dec; 181(11):7925-35. PubMed ID: 19017983
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.
Gavin AL; Hoebe K; Duong B; Ota T; Martin C; Beutler B; Nemazee D
Science; 2006 Dec; 314(5807):1936-8. PubMed ID: 17185603
[TBL] [Abstract][Full Text] [Related]
15. Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis.
Fani Maleki A; Cisbani G; Laflamme N; Prefontaine P; Plante MM; Baillargeon J; Rangachari M; Gosselin J; Rivest S
Neurotherapeutics; 2021 Apr; 18(2):889-904. PubMed ID: 33479802
[TBL] [Abstract][Full Text] [Related]
16. Pro-inflammatory adjuvant properties of pigment-grade titanium dioxide particles are augmented by a genotype that potentiates interleukin 1β processing.
Riedle S; Pele LC; Otter DE; Hewitt RE; Singh H; Roy NC; Powell JJ
Part Fibre Toxicol; 2017 Dec; 14(1):51. PubMed ID: 29216926
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvants: update on concepts].
Berinstein A; Sadir AM
Rev Argent Microbiol; 1990; 22(3):159-66. PubMed ID: 2102016
[No Abstract] [Full Text] [Related]
18. Nucleotide oligomerization domain-2 (NOD2)-induced uveitis: dependence on IFN-gamma.
Rosenzweig HL; Kawaguchi T; Martin TM; Planck SR; Davey MP; Rosenbaum JT
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1739-45. PubMed ID: 19098321
[TBL] [Abstract][Full Text] [Related]
19. The fate of nor-muramyl dipeptide (3H-labelled) after local administration in incomplete Freund's adjuvant in the guinea pig.
Hudson AM
Int J Immunopharmacol; 1984; 6(2):119-24. PubMed ID: 6735534
[TBL] [Abstract][Full Text] [Related]
20. Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.
Prakhar P; Holla S; Ghorpade DS; Gilleron M; Puzo G; Udupa V; Balaji KN
J Biol Chem; 2015 Oct; 290(44):26576-86. PubMed ID: 26391398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
